A detailed history of Financial Management Professionals, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 210 shares of HALO stock, worth $9,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares
210
Holding current value
$9,903
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$51.3 - $64.42 $10,773 - $13,528
210 New
210 $12,000
Q3 2022

Oct 27, 2022

SELL
$38.53 - $51.78 $11,559 - $15,534
-300 Reduced 96.46%
11 $0
Q1 2022

Apr 27, 2022

BUY
$31.97 - $41.06 $9,175 - $11,784
287 Added 1195.83%
311 $12,000
Q4 2021

Jan 28, 2022

BUY
$31.82 - $40.75 $350 - $448
11 Added 84.62%
24 $1,000
Q2 2021

Aug 05, 2021

BUY
$38.84 - $51.31 $504 - $667
13 New
13 $1,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.